February 22, 2022
Professor Chong Yap Seng is the Chief Clinical Officer of SICS and the Founding Director of the A*STAR-NUS Singapore Centre for Nutritional Sciences, Metabolic Disease, and Human Development. He is also a Senior Consultant in the Department of Obstetrics & Gynaecology with the National University Health System (NUHS), and the Dean of the Yong Loo Lin School of Medicine in the National University of Singapore.
A clinician-scientist with special interest in foetal growth and early development, Professor Chong is the Lead Principal Investigator for Growing Up in Singapore Towards healthy Outcomes (GUSTO) – a nationwide birth cohort study on pregnancies and early childhood development. Key discoveries on gestational diabetes and its impact on children has made systemic changes towards Singapore’s public health policy in a matter of months. Professor Chong was awarded the National Outstanding Clinician Scientist Award by the Ministry of Health in 2017.
Professor Chong received his MBBS, MMed (Obstetrics & Gynaecology) and MD from the National University of Singapore.
SINGAPORE, 7 July 2022 – MiRXES Pte Ltd, a Singapore-headquartered biotechnology company, whose mission is to save and improve lives through early, actionable, and personalized diagnoses with its innovative RNA-powered cancer early detection solutions, announced today the signing of a Memorandum of Understanding (MOU) that launched Project CADENCE (CAncer Detected Early caN be CurEd). Project CADENCE is the world’s first large-scale clinical research project for the discovery and validation of novel combinations blood-borne circulating microRNA (miRNA) and DNA methylation biomarkers that will lead to the development of a multi-cancer early detection test for up to nine high incidence and high mortality cancers, including lung, breast, colorectal, liver, stomach (gastric), esophageal, ovarian, pancreatic, and prostate cancers.
A new national consortium – the Consortium for Clinical Research and Innovation, Singapore (CRIS) – has been officially launched by the Minister for Health Mr Ong Ye Kung on 6 April 2022 CRIS brings together five key national R&D, clinical translation and service initiatives that will advance clinical research and innovation for Singapore, and establish important capabilities for a future-ready healthcare system